Louise Kornman

NUCHAL TRANSLUCENCY CANNOT BE USED AS A SCREENING TEST FOR CHROMOSOMAL ABNORMALITIES IN THE FIRST TRIMESTER OF PREGNANCY IN A ROUTINE ULTRASOUND PRACTICE

Louise Kornman, L. P. Morssink, J. R. Beekhuis et al. · Prenatal Diagnosis · 1996 · 108 citations

Fetal Medicine, Diagnosis, Gynecology +21

Prenatal Diagnosis of Fragile X Syndrome by Direct Detection of the Unstable DNA Sequence

Grant R. Sutherland, Ági K. Gedeon, Louise Kornman et al. · New England Journal of Medicine · 1991 · 108 citations · Full text

Genetic Testing, Genetics, Direct Detection +20

MATERNAL SERUM SCREENING FOR FETAL DOWN SYNDROME IN IVF PREGNANCIES

L. S. M. Ribbert, Louise Kornman, B. T. H. M. de Wolf et al. · Prenatal Diagnosis · 1996 · 80 citations

Down Syndrome, Infertility, Maternal Serum Hcg +14

Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial

Caroline A Crowther, Pat Ashwood, Chad Andersen et al. · The Lancet Child & Adolescent Health · 2019 · 80 citations · Full text

Preterm Labor, Maternal Complication, Gynecology +8

Maternal serum levels of free β-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery

Leonard P. Morssink, Louise Kornman, Terrence Hallahan et al. · Prenatal Diagnosis · 1998 · 76 citations

Fertility, Fetal Medicine, Gynecology +19